Teva Pharmaceutical Industries (Product Portfolio) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Teva Pharmaceutical Industries (Product Portfolio) General Information

Description

Portfolio of five Abbreviated New Drug Applications in the United States. The asset has five products along with Propofol Injectable Emulsion that has a sales of $340 million on a trailing twelve month basis, per IMS Health.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 5 Basel Street
  • PO Box 3190
  • Petah Tikva
  • Israel
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 5 Basel Street
  • PO Box 3190
  • Petah Tikva
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Teva Pharmaceutical Industries (Product Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Teva Pharmaceutical Industries (Product Portfolio)‘s full profile, request access.

Request a free trial

Teva Pharmaceutical Industries (Product Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Teva Pharmaceutical Industries (Product Portfolio)‘s full profile, request access.

Request a free trial

Teva Pharmaceutical Industries (Product Portfolio) FAQs

  • Where is Teva Pharmaceutical Industries (Product Portfolio) headquartered?

    Teva Pharmaceutical Industries (Product Portfolio) is headquartered in Petah Tikva, Israel.

  • What industry is Teva Pharmaceutical Industries (Product Portfolio) in?

    Teva Pharmaceutical Industries (Product Portfolio)’s primary industry is Buildings and Property.

  • Is Teva Pharmaceutical Industries (Product Portfolio) a private or public company?

    Teva Pharmaceutical Industries (Product Portfolio) is a Private company.

  • What is the current valuation of Teva Pharmaceutical Industries (Product Portfolio)?

    The current valuation of Teva Pharmaceutical Industries (Product Portfolio) is .

  • What is Teva Pharmaceutical Industries (Product Portfolio)’s current revenue?

    The current revenue for Teva Pharmaceutical Industries (Product Portfolio) is .

  • Who are Teva Pharmaceutical Industries (Product Portfolio)’s investors?

    Teva Pharmaceutical Industries has invested in Teva Pharmaceutical Industries (Product Portfolio).

  • When was Teva Pharmaceutical Industries (Product Portfolio) acquired?

    Teva Pharmaceutical Industries (Product Portfolio) was acquired on 16-Jun-2016.

  • Who acquired Teva Pharmaceutical Industries (Product Portfolio)?

    Teva Pharmaceutical Industries (Product Portfolio) was acquired by Sagent Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process